Lv3
380 积分 2023-02-07 加入
Reduced dose azacitidine plus venetoclax as maintenance therapy in acute myeloid leukaemia following intensive or low-intensity induction: a single-centre, single-arm, phase 2 trial
4小时前
待确认
Liquid biopsy in diffuse large B-cell lymphoma: utility in cell origin determination and survival prediction in Chinese patients
1年前
已完结
Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing
1年前
已完结
The Spectrum of MYC Alterations in Diffuse Large B-Cell Lymphoma
1年前
已完结
Should We Use Cell of Origin and Dual-protein Expression in Treating DLBCL?
1年前
已完结
Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas
1年前
已完结
Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas
1年前
已完结
Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial
1年前
已完结
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes
1年前
已完结
Superiority of polatuzumab vedotin over other novel agents in previously untreated ABC-type diffuse large B-cell lymphoma: a network meta-analysis of 20 RCTs
1年前
已完结
皖公网安备34019202002308
